Decoy Therapeutics Inc. Earnings Per Share (Basic)
Decoy Therapeutics Inc. (DCOY) reported Earnings Per Share (Basic) of -$4.46 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Decoy Therapeutics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$4.46.
- Decoy Therapeutics Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$4.18.
- Decoy Therapeutics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.81.
- Decoy Therapeutics Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$81.21.
- Decoy Therapeutics Inc. earnings per share, basic for fiscal 2025 was -$129.10.
- Decoy Therapeutics Inc. earnings per share, basic for fiscal 2024 was -$69.54.
- Decoy Therapeutics Inc. earnings per share, basic for fiscal 2023 was -$30.74.
- Decoy Therapeutics Inc. earnings per share, basic for fiscal 2022 was -$14.88.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.46 10-Q · filed 2026-08-12 | -$8.64 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | -$4.18 10-Q · filed 2026-05-08 | |||||||
| 2025-12-31 | -$129.10 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | -$1.81 10-Q · filed 2025-11-14 | -$14.35 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | -$81.21 10-Q · filed 2026-08-12 | -$0.45 10-Q · filed 2025-08-12 | -$253.72 10-Q · filed 2026-08-12 | -$1.41 10-Q · filed 2025-08-12 | ||||
| 2025-03-31 | -$240.07 10-Q · filed 2026-05-08 | -$1.03 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | -$69.54 10-K · filed 2026-03-31 | -$5.79 10-K · filed 2025-03-21 | ||||||
| 2024-09-30 | -$11.38 10-Q · filed 2025-11-14 | -$0.76 10-Q · filed 2024-11-14 | -$76.96 10-Q · filed 2025-11-14 | -$5.13 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | -$2.37 10-Q · filed 2025-08-12 | -$5.62 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | -$3.27 10-Q · filed 2025-05-14 | -$0.41 10-Q · filed 2024-05-13 | ||||||
| 2023-12-31 | -$30.74 10-K · filed 2025-03-21 | -$3.84 10-K · filed 2024-03-22 | ||||||
| 2023-09-30 | -$5.21 10-Q · filed 2024-11-14 | -$0.65 10-Q · filed 2023-11-09 | -$30.71 10-Q · filed 2024-11-14 | -$3.84 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | -$11.45 10-Q · filed 2024-08-09 | -$1.43 10-Q · filed 2023-08-10 | -$27.61 10-Q · filed 2024-08-09 | -$3.45 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | -$2.23 10-Q · filed 2024-05-13 | |||||||
| 2022-12-31 | -$14.88 10-K · filed 2024-03-22 | |||||||
| 2022-09-30 | -$6.41 10-Q · filed 2023-11-09 | -$12.13 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | -$2.20 10-Q · filed 2023-08-10 | -$0.09 10-Q · filed 2022-08-05 | -$5.42 10-Q · filed 2023-08-10 | -$0.22 10-Q · filed 2022-08-05 | ||||
| 2022-03-31 | -$3.30 10-Q · filed 2023-05-11 | -$0.13 10-Q · filed 2022-05-12 | ||||||
| 2021-12-31 | -$7.72 10-K · filed 2023-03-27 | -$0.31 10-K · filed 2022-03-25 | ||||||
| 2021-09-30 | -$2.09 10-Q · filed 2022-11-10 | -$0.08 10-Q · filed 2021-11-04 | -$5.41 10-Q · filed 2022-11-10 | -$0.22 10-Q · filed 2021-11-04 | ||||
| 2021-06-30 | -$0.07 10-Q · filed 2022-08-05 | -$0.13 10-Q · filed 2022-08-05 | ||||||
| 2021-03-31 | -$0.06 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | -$0.50 10-K · filed 2022-03-25 | |||||||
| 2020-09-30 | -$0.10 10-Q · filed 2021-11-04 | -$0.40 10-Q · filed 2021-11-04 | ||||||
| 2020-06-30 | -$0.13 10-Q · filed 2021-08-05 | -$0.33 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |